Study of the Apatinib Combine With POF Versus POF in Gastric Cancer

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
This study is a randomized, parallel control, multicenter,phase II study, comparing the efficacy and safety of apatinib plus POF(paclitaxel plus oxaliplatin plus 5-fluorouracil plus leucovorin) versus POF, in the first-line treatment for patients with advanced/metastatic gastric cancer.
Epistemonikos ID: 95e6801b0eb3b2c4d428d8b46e006124e90db20b
First added on: May 22, 2024